Any Infection with blastocystis is called blastocystosis. Blastocystis hominis is one common type of parasite which can be found in stools of healthy peoples also as well as peoples, who are suffering from Diarrhea, Abdominal Pain, or any other gastrointestinal discomfort.
There are some type of blastocystis, which can cause synptomatic infection along with other types of infection. However, normally these parasite simply remains in the gut and do not affect in general.
There is as such no treatment for blastocystosis, and the infection usually gets clear on its own. However, if signs and symptoms do not improve within a time period, a doctor may recommend some medicine. Research in this area is still going on, but researchers have not reached to a conclusion of exact cause of Blastocytosis.
During a prevalance study in canada Women in all provinces have a higher incidence rate by a factor of 1.23–1.53 (overall ratio 1.33). After adjusting for age and location of residence, the overall adjusted female:male incidence ratio (IR) was 1.31 (95% CI 1.23–1.40, p < 0.0001). In MB, there was a somewhat higher incidence of CD among urban dwellers (IR 1.52, p < 0.0001), whereas there was slightly high urban IR in AB (IR ratio 1.13, p = 0.06) and SK (IR ratio 1.08, n.s.), and a slightly lower rate in urban areas in NS (IR ratio 0.85, p = 0.02). The overall urban:rural IR ratio, adjusted for age, gender, and province was 1.05 (p = 0.25). The peak age of prevalence was 30–39 yr without a second peak in later years, as has been reported in the past. The prevalence on July 1, 2000 was BC (161), AB (283), SK (264), MB (271), and NS (319). The overall estimated prevalence in Canada was 234 and excluding data from BC was 279.
Peter S. Nyasulu
Prevalence and risk factors associated with acquisition of Sexually Transmitted Infections among people living with Human Immunodeficiency Virus in Diepsloot settlement, Johannesburg, South Africa PPT Version |
A novel synthetic antimicrobial peptide for the cure of gram-negative infections: Mechanism of action, efficacy in vivo, toxicity, bio-distribution and resistance selection PPT Version |
A chimeric protein (mTcd138) comprising the glucosyltransferase and domains of toxin B and the receptor binding domain of toxin A provides full protection against Clostridium difficile infection in mice PPT Version |
Significant differences between augmentation of kynurenine aminotransferase I and kynurenine aminotransferase II activities in various types of brain pathology after HIV-1 infection PPT Version |
Tracking of viral evolution during an outbreak of emerging beak and feather disease virus (BFDV) infection in the critically endangered Orange-bellied parrot (Neophema chrysogaster) PPT Version |
Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden in pregnant mice PPT Version |